Type 1 and type 2 diabetes reports emphasize areas where pharmacists can act now, including CGM, cardio-kidney therapies, and ...
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination. For pharmacists counseling patients this ...
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to ...
At 48 weeks, participants receiving the highest dose combination of 9 mg eloralintide and 15 mg tirzepatide achieved an ...
A post-hoc analysis of the REDEFINE 1 trial suggests that the investigational cagrilintide-semaglutide combination (CagriSema ...
Viral pathogens are increasingly recognized in up to 26% of adult CAP hospitalizations, with influenza and RSV historically ...
Pharmacists are moving well beyond the dispensing counter and are taking on active roles in managing patients alongside ...
Similarly, a large cross-sectional study in China evaluating individuals who recovered from COVID-19 found that 42.2% exhibited hesitancy toward subsequent doses, with higher levels of pandemic ...
Pharmacy benefit manager (PBM) reform is gaining momentum nationwide, but experts caution that pharmacies, a cornerstone of ...
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results